Yale New Haven Health has appointed Tom Jackiewicz as CEO, effective February 1, 2027, following a national search aimed at strengthening leadership.
NEW HAVEN, CT (Nov. 16, 2026) – Yale New Haven Health (YNHH), a prominent regional healthcare system, has announced the appointment of Thomas “Tom” Jackiewicz as its new chief executive officer, effective February 1, 2027. This transition comes less than five months after the organization terminated its previous CEO, highlighting a pivotal moment in YNHH’s leadership as it seeks to navigate the complexities of the modern healthcare landscape.
Jackiewicz, a highly regarded figure in the healthcare sector, previously served as the president of the University of Chicago Health System since 2020. During his tenure there, he was instrumental in achieving remarkable financial growth, which included more than doubling operating revenue and increasing operating profit sixfold. These achievements underscore his capabilities in steering health systems toward operational excellence and financial sustainability.
Professional Background
Before leading the University of Chicago Health System, Jackiewicz held significant leadership roles in other major academic health institutions. He served as CEO of Keck Medicine of the University of Southern California from 2012 to 2020 and was CEO of the University of California San Diego Health System from 2009 to 2011. His foundational experience as the chief financial officer of Health Sciences has equipped him with a comprehensive understanding of the interdependencies between financial management and clinical operations, a critical aspect for any healthcare executive.
“Tom is a seasoned and innovative leader with a proven ability to help academic health systems grow, strengthen performance, and expand access to exceptional care,” said Jack Callahan, chair of the Yale New Haven Health Board of Trustees. Callahan emphasized that Jackiewicz’s leadership approach is characterized by a nuanced understanding of organizational needs and market dynamics, allowing him to devise tailored strategies rather than relying on generic solutions.
Focus on Equity and Patient Access
During his leadership at the University of Chicago, Jackiewicz prioritized health equity and community service, particularly focusing on underserved populations on Chicago’s South Side. His strategic initiatives led to significant improvements in patient access and capacity, evidenced by an impressive leap in the Vizient ranking for access to care—from 34th place in 2020 to eighth in 2026. This ranking reflects the commitment to enhancing healthcare delivery metrics that resonate with patient needs.
Moreover, Jackiewicz has been an advocate for integrating innovative technologies within healthcare settings. His initiatives included leveraging artificial intelligence to improve patient experiences and streamline operations, particularly in automating call center tasks. This innovative mindset aligns with the ongoing transformation in healthcare, where technology plays an increasingly vital role in operational efficiency and patient engagement.
Jackiewicz’s Vision for YNHH
In his comments regarding the appointment, Jackiewicz expressed enthusiasm for the opportunity to lead YNHH at such a critical juncture. “Yale New Haven Health has an extraordinary foundation as an academic health system, with tremendous clinical expertise, talented people, and an important responsibility to the communities it serves,” he stated. “I am excited by the opportunities ahead and honored to join the organization at such an important point in its evolution.” His acknowledgment of YNHH’s potential reflects a commitment to building upon existing strengths while addressing future challenges.
Jackiewicz’s appointment follows a rigorous national search conducted by a nine-member trustee search committee, which underscores the board’s dedication to selecting a leader capable of effectively managing the complexities of contemporary healthcare delivery. Additionally, Jackiewicz’s personal ties to the region, as a native of Bridgeport, reinforce his understanding of local healthcare needs and community dynamics.
Leadership Transition and Future Directions
Jack Callahan also took the opportunity to recognize Pamela Sutton-Wallace for her exceptional service as acting CEO since June. “Under Pam’s leadership, Yale New Haven Health has continued to advance key strategic and operational priorities, including improvements in quality and safety, strengthened financial performance, and preparations for the opening of the Adams Neurosciences Center,” Callahan noted. This acknowledgment emphasizes the importance of continuity and stability during leadership transitions within healthcare organizations—critical factors for maintaining trust and operational effectiveness.
The transition to Jackiewicz as CEO may signal a new chapter for Yale New Haven Health as it continues to adapt to the evolving demands of the healthcare sector. As the organization prepares for the future, it will likely focus on enhancing patient care, expanding community health initiatives, and leveraging technological advancements to improve service delivery. Stakeholders within the healthcare community are keenly observing these developments, as they hold significant implications for YNHH’s role in addressing public health challenges in the region.



No Comment! Be the first one.